艰难梭菌相关性腹泻,Clostridium difficile-associated diarrhea
1)Clostridium difficile-associated diarrhea艰难梭菌相关性腹泻
1.Clostridium difficile-associated diarrhea (CDAD) is common among hospital-acquired bacterial diarrhea, its mortality and morbidity show an increasing trend in recent years.艰难梭菌相关性腹泻(CDAD)是医院感染性腹泻的主要原因,近年来其发病率及死亡率呈上升趋势,抗生素的频繁使用是导致CDAD的主要病因。
2.Backgroud and ObjectivesClostridium difficile-associated diarrhea(CDAD)is a more severe form of the antibiotic-associated diarrhea(AAD).背景和目的艰难梭菌相关性腹泻(Clostridium difficile-associated diarrhea,CDAD)是抗生素相关性腹泻中的一严重亚型,需要针对性的诊治。
英文短句/例句
1.Clinical Characteristics of Clostridium Difficile-associated Diarrhea艰难梭菌相关性腹泻的临床特点分析
2.Recent advances in Clostridium difficile-associated diarrhea难辨梭状芽孢杆菌相关性腹泻的认识进展
3.Clinic epidemic comparisons of Clostridium difficile-associated diarrhea with antibiotic-associated diarrhea难辨梭状芽孢杆菌相关性腹泻与抗生素相关性腹泻的临床流行病学比较
4.Clostridium Butyricum powder with antibacterials at regular intervals for preventing antibiotic-associated diarrhea酪酸梭菌活菌散与抗菌药间隔序贯应用预防抗生素相关性腹泻疗效观察
5.An observation on the efficacy of Clostridium butyricum powder in treatment of virus diarrhea in infants酪酸梭菌活菌散治疗小儿病毒性腹泻疗效观察
6.Study of Dependablity between "Pulsatilla Decoction"、Piglet Diarrhea Induced by Escherichia and Selenium“白头翁汤”、仔猪大肠杆菌性腹泻与硒相关性研究
7.Clinical studies on antimicrobial-associated diarrhea in hospitalized elderly patients老年住院患者抗菌药物相关性腹泻的临床研究
8.Prevention of antibiotic associated diarrhea by Bifid Triple Viable双歧三联活菌预防抗生素相关性腹泻的疗效
9.Effect of combined probiotics of Clostridium butyricum and Bifidobacterium infantis on intestinal flora of chronic diarrhea patients酪酸梭菌-双歧杆菌二联活菌制剂对慢性腹泻患者肠道菌群的影响
10.Clinical application of Bifidobacterium tetravaccine Tablets(Live) in prevention of infant antibiotic-associated diarrhea双歧杆菌四联活菌在预防小儿抗生素相关性腹泻的临床应用
11.Identification of Bacillary Dysentery from Other Infectious Diarrhea临床诊断细菌性痢疾区别于其他感染性腹泻相关因素分析
12.Primary study on the gene typing,molecular characteristics of virulence and resistance associated gene of 12 Clostridium difficile clinical isolates in China12株中国艰难梭菌临床分离株的基因分型、毒力和耐药相关基因分子特征研究(英文)
13.Detection and Analysis of LEE and HPI Pathogenicity Island Related Genes in Escherichia Coli Strains Isolated from Diarrheic Calfs;犊牛腹泻大肠杆菌LEE和HPI毒力岛相关基因的检测及特性分析
14.Effects of Clostridium butyricum powder with antibiotics on children with acute bacterial diarrhea酪酸梭菌活菌散联合抗菌药治疗小儿急性细菌感染性腹泻临床疗效观察
15.Analysis of 73 cases of antibiotic-associated diarrhea73例抗生素相关性腹泻的临床分析
16.of or relating to diarrhea.腹泻的或者与腹泻相关的。
17.Study on toxin characteristics of Clostridium difficile isolated from hospital临床分离艰难梭菌毒素携带特征研究
18.Clonging, Expression and Its Biological Characteristic of the Domain Gene of Clostridium Difficile Toxin B Mucosa Receptor Conjugate Region;艰难梭菌细胞毒素B羧基末端功能区的克隆、表达及其生物学特性
相关短句/例句
Clostridium difficile-associated diarrhea难辨梭状芽孢杆菌相关性腹泻
1.Clinic epidemic comparisons ofClostridium difficile-associated diarrhea with antibiotic-associated diarrhea难辨梭状芽孢杆菌相关性腹泻与抗生素相关性腹泻的临床流行病学比较
3)clostridium difficile-associated diarrhea(CDAD)艰难梭状芽孢杆菌性腹泻
4)Clostridium difficile艰难梭菌
1.Expression of clostridium difficile toxin B C-terminal repeated unit in E.coli and its immunogenicity;艰难梭菌细胞毒素B功能区的原核表达及免疫原性
2.Cloning and sequencing of the C-terminal domain gene ofClostridium difficile toxin B;艰难梭菌细胞毒素B功能区的克隆及序列分析
3.Gene cloning and high expression of clostridium difficile toxin A C-terminal repeated unit;艰难梭菌毒素A羧基端基因的克隆与表达
5)Clostridium difficile艰难梭菌(难辨梭菌)
6)chemotherapy-induced diarrhea化疗相关性腹泻
1.Study on the therapeutic regimen forchemotherapy-induced diarrhea in the patients with digestive tract carcinoma;消化道肿瘤化疗相关性腹泻的治疗研究
2.Treatment Status on Chemotherapy-induced Diarrhea with TCM;化疗相关性腹泻的中医治疗状况
3.Objective To summarize the therapeutic effect of Sandostain onchemotherapy-induced diarrhea which couldn t be cured with routine therapy.目的探讨善宁治疗常规治疗无效的严重化疗相关性腹泻的疗效。
延伸阅读
硫酸粘菌素 ,粘菌素,硫酸多粘菌素E药物名称：多粘菌素E英文名：Polymyxin E 别名： 多粘菌素E;可立斯丁;可刹迈仙干糖浆;硫酸抗敌素;硫酸粘菌素 ,粘菌素,硫酸多粘菌素E外文名：Colistin ,Polymyxin E 性状： 常用其硫酸盐，为白色或微黄色粉末；无臭或几乎无臭。有引湿性。在水中易溶，在乙醇中微溶，在丙酮、氯仿或乙醚中几乎不溶。 药理作用： 抗菌谱和体内过程与多粘菌素B相同。口服不吸收，用于治疗大肠杆菌性肠炎和对其它药物耐药的菌痢。外用于烧伤和外伤引起的绿脓杆菌局部感染和耳、眼等部位敏感菌感染。注射已少用。 适应症： 用于治疗大肠杆菌性肠炎和对其他药物耐药的菌痢。外用于烧伤和外伤引起的绿脓杆菌局部感染和耳、眼等部位敏感菌感染。注射已少用。 用量用法： 1.口服：成人１次５０万～１００万单位，１日３～４次。儿童１次量２５万～５０万单位，１日３～４次。重症时上述剂量可加倍。 2.外用：溶液剂每毫升含１万～５万单位，氯化钠注射液溶解。 注意事项： 1.可发生皮疹、瘙痒等过敏症状。胃肠道有恶心、呕吐、食欲不振、腹泻等不良反应。 2.孕妇慎用。 3.口服宜空腹给药。 规格： 片剂：每片50万;100万;300万单位。灭菌粉剂：每瓶１００万单位，供制备溶液用（１ｍｇ＝６５００单位） 类别：抗生素
